However, two more recent analyses of these pivotal early studies continue to demonstrate significant associations between PD-L1 expression, tumor mutational burden (TMB), and response to ICI treatment; both studies also demonstrate a consistent effect regardless of tumor HPV status (141, 142). The gene discussed is CD274; the disease is neoplasm.